Product Information
DEXTROAMP-AMPHETAMIN 10 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.2327 per EA under NDC 16714095001. Its NADAC has been published 375 times since Jul 31, 2019.
FDA first approved this application on Nov 27, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 10 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
NorthStar Rx LLCNDC
16714095001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202424FDA Approved
11/27/2013
TE Code
AB
On Market Since
3/20/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has been published 375 times since Jul 31, 2019, and over the history we have for it it has declined 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2327 per EA |
|---|---|
| All-time high | $0.4729 (Oct 16, 2019) |
| All-time low | $0.1975 (Nov 20, 2024) |
| 52-week high | $0.2513 |
| 52-week low | $0.2327 |
| Median price | $0.2571 |
| Average price | $0.2826 |
| Largest weekly change | +39.7% (May 17, 2023) |
| Weeks tracked | 375 |
| Tracking since | Jul 31, 2019 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 10 MG TAB, manufactured by NorthStar Rx LLC, is $0.2327 per EA (NDC 16714095001), effective Sep 30, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 10 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has declined 47.4%. It has been tracked across 375 weekly CMS publications since Jul 31, 2019.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 10 MG TAB?
Since Jul 31, 2019, the NADAC for DEXTROAMP-AMPHETAMIN 10 MG TAB has ranged from a low of $0.1975 (Nov 20, 2024) to a high of $0.4729 (Oct 16, 2019), with a median of $0.2571 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 10 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAMIN 10 MG TAB?
DEXTROAMP-AMPHETAMIN 10 MG TAB (NDC 16714095001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.